title: Regulatory forum opinion piece*: immunotoxicology assessments in nonhuman primates--challenges and opportunities.
abstract: The immune system has been recognized for decades as a potential "target organ" of toxicity. Immune system activation can result in cytokine release resulting in severe systemic toxicity. Immunosuppression can result in impaired host defense and an increase in opportunistic infection, reemergence of latent infection, poor responses to vaccination, or increased risk of certain cancers. Several regulatory documents have addressed various aspects of immunotoxicity assessments. Nonhuman primates (NHPs) and in particular macaques are often the only relevant species for biotechnology-derived investigational new drugs based on cross-reactivity with human and NHP targets. This article reviews the challenges and opportunities associated with monitoring immune function in NHPs in the context of regulatory expectations. The article emphasizes how a comprehensive assessment of immunotoxicity remains a challenge due to interanimal variability associated with certain parameters (e.g., T-dependent antibody response)and it identifies gaps, such as the stage of development of certain assays (e.g., cytotoxic T-cell function). Despite these challenges, a thorough assessment of target biology-driven theoretical risks, in combination with proper integration of all information from the standard toxicology studies, and the refinement of certain assays should enable proper risk assessment. To this effect, emphasis should be placed on leveraging predictive in vitro assays using human cells.
authors.affiliation: Amgen Inc., Seattle, WA 98119, USA. hlebrec@amgen.com
authors.forename: Hervé N
authors.initials: HN
authors.lastname: Lebrec
mesh_terms: D000276:Adjuvants, Immunologic / Q000633:toxicity; D000818:Animals; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D005260:Female; D007107:Immune System / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000633:toxicity; D008253:Macaca mulatta; D008297:Male; D011323:Primates; D018675:Toxicity Tests / Q000379:methods*; D014116:Toxicology
chemical_list: D000276:Adjuvants, Immunologic; D007166:Immunosuppressive Agents